Search

Your search keyword '"Tewari, Krishnansu S."' showing total 27 results
Start Over Author "Tewari, Krishnansu S." Publisher american association for cancer research (aacr)
27 results on '"Tewari, Krishnansu S."'

1. Supplementary Data from Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology—Gynecologic Oncology Group Study 240 (NCT 00803062)

Author

Tewari, Krishnansu S., primary, Sill, Michael W., primary, Monk, Bradley J., primary, Penson, Richard T., primary, Moore, David H., primary, Lankes, Heather A., primary, Ramondetta, Lois M., primary, Landrum, Lisa M., primary, Randall, Leslie M., primary, Oaknin, Ana, primary, Leitao, Mario M., primary, Eisenhauer, Eric L., primary, DiSilvestro, Paul, primary, Van Le, Linda, primary, Pearl, Michael L., primary, Burke, James J., primary, Salani, Ritu, primary, Richardson, Debra L., primary, Michael, Helen E., primary, Kindelberger, David W., primary, and Birrer, Michael J., primary

Published
2023
Full Text
View/download PDF

2. Supplementary Data from Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology—Gynecologic Oncology Group Study 240 (NCT 00803062)

Author

Tewari, Krishnansu S., primary, Sill, Michael W., primary, Monk, Bradley J., primary, Penson, Richard T., primary, Moore, David H., primary, Lankes, Heather A., primary, Ramondetta, Lois M., primary, Landrum, Lisa M., primary, Randall, Leslie M., primary, Oaknin, Ana, primary, Leitao, Mario M., primary, Eisenhauer, Eric L., primary, DiSilvestro, Paul, primary, Van Le, Linda, primary, Pearl, Michael L., primary, Burke, James J., primary, Salani, Ritu, primary, Richardson, Debra L., primary, Michael, Helen E., primary, Kindelberger, David W., primary, and Birrer, Michael J., primary

Published
2023
Full Text
View/download PDF

3. Supplementary Data from Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology—Gynecologic Oncology Group Study 240 (NCT 00803062)

Author

Tewari, Krishnansu S., primary, Sill, Michael W., primary, Monk, Bradley J., primary, Penson, Richard T., primary, Moore, David H., primary, Lankes, Heather A., primary, Ramondetta, Lois M., primary, Landrum, Lisa M., primary, Randall, Leslie M., primary, Oaknin, Ana, primary, Leitao, Mario M., primary, Eisenhauer, Eric L., primary, DiSilvestro, Paul, primary, Van Le, Linda, primary, Pearl, Michael L., primary, Burke, James J., primary, Salani, Ritu, primary, Richardson, Debra L., primary, Michael, Helen E., primary, Kindelberger, David W., primary, and Birrer, Michael J., primary

Published
2023
Full Text
View/download PDF

4. Supplementary Data from Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology—Gynecologic Oncology Group Study 240 (NCT 00803062)

Author

Tewari, Krishnansu S., primary, Sill, Michael W., primary, Monk, Bradley J., primary, Penson, Richard T., primary, Moore, David H., primary, Lankes, Heather A., primary, Ramondetta, Lois M., primary, Landrum, Lisa M., primary, Randall, Leslie M., primary, Oaknin, Ana, primary, Leitao, Mario M., primary, Eisenhauer, Eric L., primary, DiSilvestro, Paul, primary, Van Le, Linda, primary, Pearl, Michael L., primary, Burke, James J., primary, Salani, Ritu, primary, Richardson, Debra L., primary, Michael, Helen E., primary, Kindelberger, David W., primary, and Birrer, Michael J., primary

Published
2023
Full Text
View/download PDF

5. Supplementary Table from Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial

Author

Lee, Jung-Min, primary, Moore, Richard G., primary, Ghamande, Sharad, primary, Park, Min S., primary, Diaz, John P., primary, Chapman, Julia, primary, Kendrick, James, primary, Slomovitz, Brian M., primary, Tewari, Krishnansu S., primary, Lowe, Elizabeth S., primary, Milenkova, Tsveta, primary, Kumar, Sanjeev, primary, Dymond, Mike, primary, Brown, Jessica, primary, and Liu, Joyce F., primary

Published
2023
Full Text
View/download PDF

6. Figure S6 (A-D) from Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218

Author

Alvarez Secord, Angeles, primary, Bell Burdett, Kirsten, primary, Owzar, Kouros, primary, Tritchler, David, primary, Sibley, Alexander B., primary, Liu, Yingmiao, primary, Starr, Mark D., primary, Brady, J. Chris, primary, Lankes, Heather A., primary, Hurwitz, Herbert I., primary, Mannel, Robert S., primary, Tewari, Krishnansu S., primary, O'Malley, David M., primary, Gray, Heidi, primary, Bakkum-Gamez, Jamie N., primary, Fujiwara, Keiichi, primary, Boente, Matthew, primary, Deng, Wei, primary, Burger, Robert A., primary, Birrer, Michael J., primary, and Nixon, Andrew B., primary

Published
2023
Full Text
View/download PDF

7. Supplementary Table from Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial

Author

Lee, Jung-Min, primary, Moore, Richard G., primary, Ghamande, Sharad, primary, Park, Min S., primary, Diaz, John P., primary, Chapman, Julia, primary, Kendrick, James, primary, Slomovitz, Brian M., primary, Tewari, Krishnansu S., primary, Lowe, Elizabeth S., primary, Milenkova, Tsveta, primary, Kumar, Sanjeev, primary, Dymond, Mike, primary, Brown, Jessica, primary, and Liu, Joyce F., primary

Published
2023
Full Text
View/download PDF

8. Supplementary Table from Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial

Author

Lee, Jung-Min, primary, Moore, Richard G., primary, Ghamande, Sharad, primary, Park, Min S., primary, Diaz, John P., primary, Chapman, Julia, primary, Kendrick, James, primary, Slomovitz, Brian M., primary, Tewari, Krishnansu S., primary, Lowe, Elizabeth S., primary, Milenkova, Tsveta, primary, Kumar, Sanjeev, primary, Dymond, Mike, primary, Brown, Jessica, primary, and Liu, Joyce F., primary

Published
2023
Full Text
View/download PDF

9. Table S3 from Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218

Author

Alvarez Secord, Angeles, primary, Bell Burdett, Kirsten, primary, Owzar, Kouros, primary, Tritchler, David, primary, Sibley, Alexander B., primary, Liu, Yingmiao, primary, Starr, Mark D., primary, Brady, J. Chris, primary, Lankes, Heather A., primary, Hurwitz, Herbert I., primary, Mannel, Robert S., primary, Tewari, Krishnansu S., primary, O'Malley, David M., primary, Gray, Heidi, primary, Bakkum-Gamez, Jamie N., primary, Fujiwara, Keiichi, primary, Boente, Matthew, primary, Deng, Wei, primary, Burger, Robert A., primary, Birrer, Michael J., primary, and Nixon, Andrew B., primary

Published
2023
Full Text
View/download PDF

10. Figure S1, Table S2 from Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study

Author

Norquist, Barbara M., primary, Brady, Mark F., primary, Harrell, Maria I., primary, Walsh, Tom, primary, Lee, Ming K., primary, Gulsuner, Suleyman, primary, Bernards, Sarah S., primary, Casadei, Silvia, primary, Burger, Robert A., primary, Tewari, Krishnansu S., primary, Backes, Floor, primary, Mannel, Robert S., primary, Glaser, Gretchen, primary, Bailey, Cheryl, primary, Rubin, Stephen, primary, Soper, John, primary, Lankes, Heather A., primary, Ramirez, Nilsa C., primary, King, Mary Claire, primary, Birrer, Michael J., primary, and Swisher, Elizabeth M., primary

Published
2023
Full Text
View/download PDF

11. Supplementary Data from Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial

Author

Lee, Jung-Min, primary, Moore, Richard G., primary, Ghamande, Sharad, primary, Park, Min S., primary, Diaz, John P., primary, Chapman, Julia, primary, Kendrick, James, primary, Slomovitz, Brian M., primary, Tewari, Krishnansu S., primary, Lowe, Elizabeth S., primary, Milenkova, Tsveta, primary, Kumar, Sanjeev, primary, Dymond, Mike, primary, Brown, Jessica, primary, and Liu, Joyce F., primary

Published
2023
Full Text
View/download PDF

12. Figure S1, Table S2 from Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study

Author

Norquist, Barbara M., primary, Brady, Mark F., primary, Harrell, Maria I., primary, Walsh, Tom, primary, Lee, Ming K., primary, Gulsuner, Suleyman, primary, Bernards, Sarah S., primary, Casadei, Silvia, primary, Burger, Robert A., primary, Tewari, Krishnansu S., primary, Backes, Floor, primary, Mannel, Robert S., primary, Glaser, Gretchen, primary, Bailey, Cheryl, primary, Rubin, Stephen, primary, Soper, John, primary, Lankes, Heather A., primary, Ramirez, Nilsa C., primary, King, Mary Claire, primary, Birrer, Michael J., primary, and Swisher, Elizabeth M., primary

Published
2023
Full Text
View/download PDF

13. Supplementary Figure 1 Legend from Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study

Author

Tewari, Krishnansu S., primary, Sill, Michael W., primary, Monk, Bradley J., primary, Penson, Richard T., primary, Long, Harry J., primary, Poveda, Andrés, primary, Landrum, Lisa M., primary, Leitao, Mario M., primary, Brown, Jubilee, primary, Reid, Thomas J.A., primary, Michael, Helen E., primary, and Moore, David H., primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure from Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial

Author

Lee, Jung-Min, primary, Moore, Richard G., primary, Ghamande, Sharad, primary, Park, Min S., primary, Diaz, John P., primary, Chapman, Julia, primary, Kendrick, James, primary, Slomovitz, Brian M., primary, Tewari, Krishnansu S., primary, Lowe, Elizabeth S., primary, Milenkova, Tsveta, primary, Kumar, Sanjeev, primary, Dymond, Mike, primary, Brown, Jessica, primary, and Liu, Joyce F., primary

Published
2023
Full Text
View/download PDF

15. Supplementary Figure 1 Legend from Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study

Author

Tewari, Krishnansu S., primary, Sill, Michael W., primary, Monk, Bradley J., primary, Penson, Richard T., primary, Long, Harry J., primary, Poveda, Andrés, primary, Landrum, Lisa M., primary, Leitao, Mario M., primary, Brown, Jubilee, primary, Reid, Thomas J.A., primary, Michael, Helen E., primary, and Moore, David H., primary

Published
2023
Full Text
View/download PDF

16. Figure S5 from Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218

Author

Alvarez Secord, Angeles, primary, Bell Burdett, Kirsten, primary, Owzar, Kouros, primary, Tritchler, David, primary, Sibley, Alexander B., primary, Liu, Yingmiao, primary, Starr, Mark D., primary, Brady, J. Chris, primary, Lankes, Heather A., primary, Hurwitz, Herbert I., primary, Mannel, Robert S., primary, Tewari, Krishnansu S., primary, O'Malley, David M., primary, Gray, Heidi, primary, Bakkum-Gamez, Jamie N., primary, Fujiwara, Keiichi, primary, Boente, Matthew, primary, Deng, Wei, primary, Burger, Robert A., primary, Birrer, Michael J., primary, and Nixon, Andrew B., primary

Published
2023
Full Text
View/download PDF

17. Supplementary Figure 1 from Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study

Author

Tewari, Krishnansu S., primary, Sill, Michael W., primary, Monk, Bradley J., primary, Penson, Richard T., primary, Long, Harry J., primary, Poveda, Andrés, primary, Landrum, Lisa M., primary, Leitao, Mario M., primary, Brown, Jubilee, primary, Reid, Thomas J.A., primary, Michael, Helen E., primary, and Moore, David H., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figure from Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial

Author

Lee, Jung-Min, primary, Moore, Richard G., primary, Ghamande, Sharad, primary, Park, Min S., primary, Diaz, John P., primary, Chapman, Julia, primary, Kendrick, James, primary, Slomovitz, Brian M., primary, Tewari, Krishnansu S., primary, Lowe, Elizabeth S., primary, Milenkova, Tsveta, primary, Kumar, Sanjeev, primary, Dymond, Mike, primary, Brown, Jessica, primary, and Liu, Joyce F., primary

Published
2023
Full Text
View/download PDF

19. Supplementary Table from Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial

Author

Lee, Jung-Min, primary, Moore, Richard G., primary, Ghamande, Sharad, primary, Park, Min S., primary, Diaz, John P., primary, Chapman, Julia, primary, Kendrick, James, primary, Slomovitz, Brian M., primary, Tewari, Krishnansu S., primary, Lowe, Elizabeth S., primary, Milenkova, Tsveta, primary, Kumar, Sanjeev, primary, Dymond, Mike, primary, Brown, Jessica, primary, and Liu, Joyce F., primary

Published
2023
Full Text
View/download PDF

20. Supplementary Data from Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial

Author

Lee, Jung-Min, primary, Moore, Richard G., primary, Ghamande, Sharad, primary, Park, Min S., primary, Diaz, John P., primary, Chapman, Julia, primary, Kendrick, James, primary, Slomovitz, Brian M., primary, Tewari, Krishnansu S., primary, Lowe, Elizabeth S., primary, Milenkova, Tsveta, primary, Kumar, Sanjeev, primary, Dymond, Mike, primary, Brown, Jessica, primary, and Liu, Joyce F., primary

Published
2023
Full Text
View/download PDF

21. Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial

Author

Lee, Jung-Min, primary, Moore, Richard G., additional, Ghamande, Sharad, additional, Park, Min S., additional, Diaz, John P., additional, Chapman, Julia, additional, Kendrick, James, additional, Slomovitz, Brian M., additional, Tewari, Krishnansu S., additional, Lowe, Elizabeth S., additional, Milenkova, Tsveta, additional, Kumar, Sanjeev, additional, Dymond, Mike, additional, Brown, Jessica, additional, and Liu, Joyce F., additional

Published
2022
Full Text
View/download PDF

22. Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology—Gynecologic Oncology Group Study 240 (NCT 00803062)

Author

Tewari, Krishnansu S., primary, Sill, Michael W., additional, Monk, Bradley J., additional, Penson, Richard T., additional, Moore, David H., additional, Lankes, Heather A., additional, Ramondetta, Lois M., additional, Landrum, Lisa M., additional, Randall, Leslie M., additional, Oaknin, Ana, additional, Leitao, Mario M., additional, Eisenhauer, Eric L., additional, DiSilvestro, Paul, additional, Van Le, Linda, additional, Pearl, Michael L., additional, Burke, James J., additional, Salani, Ritu, additional, Richardson, Debra L., additional, Michael, Helen E., additional, Kindelberger, David W., additional, and Birrer, Michael J., additional

Published
2020
Full Text
View/download PDF

23. Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218

Author

Alvarez Secord, Angeles, primary, Bell Burdett, Kirsten, additional, Owzar, Kouros, additional, Tritchler, David, additional, Sibley, Alexander B., additional, Liu, Yingmiao, additional, Starr, Mark D., additional, Brady, J. Chris, additional, Lankes, Heather A., additional, Hurwitz, Herbert I., additional, Mannel, Robert S., additional, Tewari, Krishnansu S., additional, O'Malley, David M., additional, Gray, Heidi, additional, Bakkum-Gamez, Jamie N., additional, Fujiwara, Keiichi, additional, Boente, Matthew, additional, Deng, Wei, additional, Burger, Robert A., additional, Birrer, Michael J., additional, and Nixon, Andrew B., additional

Published
2020
Full Text
View/download PDF

24. Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study

Author

Norquist, Barbara M., primary, Brady, Mark F., additional, Harrell, Maria I., additional, Walsh, Tom, additional, Lee, Ming K., additional, Gulsuner, Suleyman, additional, Bernards, Sarah S., additional, Casadei, Silvia, additional, Burger, Robert A., additional, Tewari, Krishnansu S., additional, Backes, Floor, additional, Mannel, Robert S., additional, Glaser, Gretchen, additional, Bailey, Cheryl, additional, Rubin, Stephen, additional, Soper, John, additional, Lankes, Heather A., additional, Ramirez, Nilsa C., additional, King, Mary Claire, additional, Birrer, Michael J., additional, and Swisher, Elizabeth M., additional

Published
2018
Full Text
View/download PDF

25. Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study

Author

Tewari, Krishnansu S., primary, Sill, Michael W., additional, Monk, Bradley J., additional, Penson, Richard T., additional, Long, Harry J., additional, Poveda, Andrés, additional, Landrum, Lisa M., additional, Leitao, Mario M., additional, Brown, Jubilee, additional, Reid, Thomas J.A., additional, Michael, Helen E., additional, and Moore, David H., additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results